1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップ・アプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要産業動向
5 子宮内避妊器具の世界市場
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 製品別市場構成
5.5 用途別市場構成比
5.6 地域別市場構成
5.7 市場予測
5.8 SWOT分析
5.8.1 概要
5.8.2 強み
5.8.3 弱点
5.8.4 機会
5.8.5 脅威
5.9 バリューチェーン分析
5.9.1 概要
5.9.2 研究開発
5.9.3 原材料調達
5.9.4 製造
5.9.5 マーケティング
5.9.6 流通
5.9.7 最終用途
5.10 ポーターズファイブフォース分析
5.10.1 概要
5.10.2 買い手の交渉力
5.10.3 供給者の交渉力
5.10.4 競争の程度
5.10.5 新規参入の脅威
5.10.6 代替品の脅威
6 製品別市場構成
6.1 ホルモン子宮内避妊具
6.1.1 市場動向
6.1.2 市場予測
6.2 銅製子宮内避妊具
6.2.1 市場動向
6.2.2 市場予測
7 エンドユーザー別市場内訳
7.1 病院
7.1.1 市場動向
7.1.2 市場予測
7.2 婦人科クリニック
7.2.1 市場動向
7.2.2 市場予測
7.3 地域医療
7.3.1 市場動向
7.3.2 市場予測
7.4 その他
7.4.1 市場動向
7.4.2 市場予測
8 地域別市場内訳
8.1 欧州
8.1.1 市場動向
8.1.2 市場予測
8.2 北米
8.2.1 市場動向
8.2.2 市場予測
8.3 アジア太平洋
8.3.1 市場動向
8.3.2 市場予測
8.4 中東・アフリカ
8.4.1 市場動向
8.4.2 市場予測
8.5 中南米
8.5.1 市場動向
8.5.2 市場予測
9 子宮内避妊具の製造工程
9.1 製品概要
9.2 原材料要件
9.3 製造プロセス
9.4 主な成功要因とリスク要因
10 競争環境
10.1 市場構造
10.2 主要プレーヤー
10.3 主要企業のプロファイル
10.3.1 アクタビス
10.3.2 バイエル
10.3.3 テバ・ファーマシューティカルズ
10.3.4 アラガン
10.3.5 アニ・ファーマシューティカルズ
10.3.6 ユーロジン
10.3.7 オコンメディカル
10.3.8 プレグナ
10.3.9 SMBコーポレーション
10.3.10 HLLライフケア
10.3.11 HRAファーマ
10.3.12 ベシンズ・ヘルスケア
図1：世界：子宮内デバイス市場：主な推進要因と課題
図2：世界：子宮内避妊器具市場：販売額（単位：億米ドル）、2019年～2024年
図3：世界：子宮内避妊具市場：子宮内避妊器具の世界市場：製品別構成比（単位：%）、2024年
図4：子宮内避妊器具の世界市場：製品別構成比（単位：%）、2024年子宮内避妊器具の世界市場：用途別構成比（%）、2024年
図5：子宮内避妊器具の世界市場：用途別構成比（単位：%）、2024年子宮内避妊器具の世界市場：地域別構成比（%）、2024年
図6：子宮内避妊器具の世界市場予測：販売額（単位：億ドル）、2025年～2033年
図7：世界：子宮内避妊器具産業：SWOT分析
図8：世界：子宮内避妊器具産業：SWOT分析バリューチェーン分析
図9: 世界の子宮内装置産業：バリューチェーン分析ポーターのファイブフォース分析
図10: 子宮内避妊器具（ホルモン）の世界市場：販売額（単位：百万米ドル）、2019年および2024年
図11：世界：子宮内避妊器具（ホルモン剤）市場予測：販売額（単位：百万ドル）、2025年～2033年
図12: 子宮内避妊器具(銅製)の世界市場：販売額（単位：百万ドル）、2019年・2024年
図13: 子宮内避妊器具(銅)の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図14：子宮内避妊器具の世界市場（病院における最終用途）：販売額（単位：百万米ドル）、2019年・2024年
図15：子宮内避妊器具（病院における最終用途）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図16：子宮内避妊器具の世界市場（婦人科クリニックにおける最終用途）：販売額（単位：百万米ドル）、2019年および2024年
図17：子宮内避妊器具（婦人科クリニックにおける最終用途）の世界市場予測：販売額（単位：百万米ドル）、2025年-2033年
図18：子宮内避妊器具（地域医療における最終用途）の世界市場予測：販売額（単位：百万ドル販売額（単位：百万米ドル）、2019年・2024年
図19：子宮内避妊器具（地域医療における最終用途）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図20：子宮内避妊器具の世界市場（その他の最終用途）：販売額（単位：百万米ドル）、2019年・2024年
図21：子宮内避妊器具（その他の最終用途）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図22: 欧州: 子宮内デバイス市場：販売金額（単位：百万USドル）、2019年・2024年
図23: 欧州: 子宮内デバイス市場予測：販売額（単位：百万米ドル）、2025年～2033年
図24: 北米: 子宮内避妊具市場：販売額（単位：百万米ドル）、2019年および2024年
図25：北米：子宮内デバイス市場予測：販売金額（単位：百万ドル）、2025年～2033年
図26：アジア太平洋地域：子宮内避妊器具市場：販売金額（単位：百万USドル）、2019年および2024年
図27：アジア太平洋地域：子宮内デバイス市場予測：販売額（単位：百万米ドル）、2025年～2033年
図28：中東・アフリカ：子宮内避妊器具市場：販売額（単位：百万USドル）、2019年および2024年
図29：中東・アフリカ：子宮内避妊器具市場の予測：販売額（単位：百万ドル）、2025年～2033年
図30：中南米：子宮内避妊器具市場：販売金額（単位：百万USドル）、2019年および2024年
図31：ラテンアメリカ：子宮内デバイス市場予測：販売金額（単位：百万USドル）、2025年～2033年
図32：子宮内避妊器具の製造：詳細なプロセスフロー
[表一覧］
表1：世界：子宮内デバイス市場：主要産業ハイライト：2024年、2033年
表2：子宮内避妊器具の世界市場予測：製品別内訳（単位：百万米ドル）、2025年-2033年
表3：子宮内避妊器具の世界市場予測：子宮内避妊器具の世界市場予測：用途別構成比（単位：百万米ドル）、2025-2033年
表4：子宮内避妊器具の世界市場予測：地域別構成比（単位：百万ドル）、2025-2033年
表5：子宮内避妊器具の製造：原材料所要量
表6：子宮内避妊器具の世界市場：競争構造
表7：子宮内避妊器具の世界市場：競合構造主要企業
The global intrauterine devices market size reached USD 4.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.8 Billion by 2033, exhibiting a growth rate (CAGR) of 3.87% during 2025-2033. The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access.
Intrauterine Devices (IUDs) are a form of long-term, reversible birth control, representing one of the most effective contraceptive methods available today. An IUD is a small, T-shaped device that is inserted into the uterus by a healthcare provider to prevent pregnancy. There are two main types of IUDs: copper IUDs, which release a small amount of copper to deter sperm from reaching the egg, and hormonal IUDs, which release hormones to thicken cervical mucus and block sperm from fertilizing the egg. IUDs provide an extended period of protection, ranging from three to ten years, depending on the type. They offer the convenience of minimal ongoing care and are favored for their efficacy, reversibility, and ease of use.
The global market is primarily driven by the increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods. In line with this, the growing preference for reversible and hassle-free birth control options is also providing an impetus to the market. Moreover, the support and educational initiatives by healthcare providers and organizations about the benefits and usage of IUDs are acting as significant growth-inducing factors for the market. In addition to this, the endorsement of IUDs by medical professionals, owing to their safety and reliability, is encouraging the expansion of the market. Also, the rise in government initiatives promoting family planning and reproductive health education is impacting the market positively. The market is further driven by favorable healthcare policies and insurance coverage, which make IUDs more accessible and affordable to a broader population.
Intrauterine Devices (IUD) Market Trends/Drivers:
Rising trend of population control efforts
The growing awareness of sustainable development has led governments and international organizations to prioritize population control efforts. This significant shift in policy direction is reinforcing the role of effective and long-term contraceptive methods such as IUDs. Also, various collaborative programs among governmental bodies of several countries, NGOs, and manufacturers aim to promote IUDs as a preferred method of family planning. These alliances often result in extensive campaigns, distribution networks, and educational outreach, making IUDs more accessible and acceptable to diverse populations. Additionally, tailored interventions and subsidies in various regions further facilitate the adoption of IUDs. This global movement towards population control, with an emphasis on responsible family planning and reproductive choices, stands as a powerful driver for the IUD market, fueling both demand and innovation.
Growing female workforce participation
The rise in the female workforce's participation marks a cultural and economic shift, influencing various aspects of life, including reproductive choices. As women continue to take on professional roles, the need for convenient, reliable, and low-maintenance contraceptive methods has grown. IUDs, known for their extended effectiveness and minimal ongoing care, resonate with the lifestyle needs of working women. They provide the flexibility and assurance that many seek in balancing their careers and personal lives. Moreover, employers and healthcare providers are increasingly recognizing these needs, offering support and coverage for IUDs as part of comprehensive health benefits. This alignment of market supply with the real-life demands of a growing segment of the population is not just a trend but a substantial driving force in the IUD market.
Continual advancements in medical technology and research
The healthcare industry is marked by continuous advancements in medical technology and research, and the field of contraception is no exception. Innovations in materials, designs, and hormone delivery mechanisms have led to the development of more advanced and user-friendly IUDs. The drive for improvement is fueled by investment in research and development by leading companies in the field, often in collaboration with healthcare providers and research institutions. These partnerships enable a deeper understanding of user needs, preferences, and medical requirements, guiding the design and functionality of new IUD models. This focus on innovation ensures that IUDs remain at the forefront of contraceptive technology, offering choices that are not only effective but also aligned with the comfort and well-being of users. The investment in technological progress underscores the commitment to enhancing reproductive health, making it a pivotal driver in the IUD market growth.
Intrauterine Devices (IUD) Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global intrauterine devices market report, along with forecasts at the global and regional levels from 2025-2033. Our report has categorized the market based on product and end-use.
Breakup by Product:
• Hormonal Intrauterine Device
• Copper Intrauterine Device
Hormonal intrauterine device (IUD) represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the product. This includes hormonal intrauterine device, and copper intrauterine device. According to the report, hormonal intrauterine devices (IUD) represented the largest segment.
The demand for hormonal IUDs is growing due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many. Their suitability for extended usage of up to 3-7 years offers long-term solutions without the need for daily intervention. The ability to return to normal fertility after removal adds to their appeal. Many users also find them to be a preferable non-surgical option, contributing to their popularity. The combined factors of effectiveness, longevity, reversibility, and non-surgical nature make this segment an integral part of the global IUD market.
On the other hand, copper IUDs offer a contraceptive method without the use of hormones, appealing to those who want to avoid hormonal intervention. They provide a cost-effective solution, often entailing only a one-time expense. The protection they offer is long-lasting, often effective for up to 10 years, making them an attractive long-term option. These factors together make copper IUDs a significant segment, reflecting the various preferences and financial considerations of the global population.
Breakup by End-Use:
• Hospitals
• Gynaecology Clinics
• Community Healthcare
• Others
The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals, gynaecology clinics, community healthcare, others.
In the hospitals segment, the availability of specialized professionals ensures access to expert care, while the use of modern tools and technologies facilitates insertion. Comprehensive services, including consultation, insertion, and follow-up, create a streamlined patient experience. Hospitals continue to be a core setting for IUD administration, integrating specialized care with state-of-the-art technology to serve a broad population base.
On the other hand, gynaecology clinics are seeing growth in IUD administrations owing to their focused expertise in women’s reproductive health. They offer personalized care tailored to individual needs and are often more accessible than hospitals for many patients. This specialized, accessible, and personalized care makes gynaecology clinics an essential part of the landscape, serving a diverse clientele with varying needs and preferences.
Furthermore, community healthcare segment of the market is impelled by the introduction of affordable and often lower-cost services. Accessibility in remote and underserved areas ensures that more people can avail themselves of these devices. Education and outreach are significant components of this segment, with community health providers offering necessary information and support. This approach fosters a wider reach and makes IUDs available to populations that might otherwise have limited access.
Breakup by Region:
• Europe
• North America
• Asia Pacific
• Middle East and Africa
• Latin America
North America exhibits a clear dominance, accounting for the largest intrauterine devices (IUD) market share
The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.
The North America region's IUD market is driven by several factors, forming a complex and synergistic landscape that fosters growth. The well-developed healthcare infrastructure ensures robust availability and service delivery, making both hormonal and copper IUDs accessible to a wide range of the population.
Regulatory support in this region fosters a generally favorable environment for IUDs, with clear guidelines and standards that help maintain quality and safety. Economic factors, particularly higher income levels, facilitate more accessible healthcare services, allowing for a broader spectrum of the population to avail themselves of this contraceptive method. These financial considerations also support ongoing research and development in the field, leading to potential innovations and improvements in IUD technology.
The positively changing cultural attitudes towards reproductive health is contributing to a more open dialogue and acceptance of various contraceptive options, including IUDs. The integration of advanced medical practices and continual professional development among healthcare providers further enhances the region's ability to offer state-of-the-art care.
Competitive Landscape:
The leading companies are investing in research and development (R&D) activities to create new and improved IUDs. These innovations often focus on enhancing effectiveness, reducing side effects, and increasing user comfort. The key players are also exploring new markets and expanding into emerging economies to utilize opportunities in areas where contraceptive methods like IUDs may be less prevalent. To enhance awareness and acceptance of IUDs, the major companies are engaging in educational campaigns by working with healthcare providers and community organizations to provide accurate product information. Furthermore, the top players are working closely with regulatory bodies to ensure that their products comply with local laws and guidelines, maintaining quality and safety. Apart from this, they are also diversifying their portfolio and offering products at various price points, to make IUDs accessible to a broader range of income levels.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
• Actavis
• Bayer
• Teva Pharmaceuticals
• Allergan
• ANI Pharmaceuticals
• Eurogine
• OCON Medical
• Pregna
• SMB Corporation
• HLL Lifecare
• HRA Pharma
• Besins HealthCare
Key Questions Answered in This Report
1.What was the size of the global in-mold labels market in 2024?
2.What is the expected growth rate of the global in-mold labels market during 2025-2033?
3.What are the key factors driving the global in-mold labels market?
4.What has been the impact of COVID-19 on the global in-mold labels market?
5.What is the breakup of the global in-mold labels market based on the material?
6.What is the breakup of the global in-mold labels market based on the technology?
7.What is the breakup of the global in-mold labels market based on printing technology?
8.What is the breakup of the global in-mold labels market based on the printing inks?
9. What is the breakup of the global in-mold labels market based on the end-use?
10.What are the key regions in the global in-mold labels market?
11.Who are the key players/companies in the global in-mold labels market?
